|
|
Article: NeoPharm Trades on The American Stock Exchange; Company Transfers its Common Stock From the Nasdaq Small Cap
- Article from:
- PR Newswire
- Article date:
- December 2, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, Dec. 2 /PRNewswire/ -- The American Stock Exchange today began trading the common stock of NeoPharm, Inc., a biopharmaceutical company engaged in the research and development of drugs for various cancer diagnoses and treatment.
NeoPharm, Inc., based in Lake Forest, Illinois, has developed a broad portfolio of cancer compounds in various stages of clinical and pre-clinical development. The two compounds closest to commercialization are BUdR (broxuridine) and IUdR (idoxuridine), a class of drugs known as radiosensitizers. NeoPharm acquired rights to these drugs from the National Cancer Institute and they are the subject of a Cooperative Research and ...